XYLO TECHNOLOGIES LTD (XYLO) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
XYLO currently has 32.3M outstanding shares. with significant dilution risk as 80.7M authorized shares could dilute existing holders by 250.2%. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 30, 2025 |
20-F filing | 32.3M shares outstanding |
32M | 81M |
| Apr 22, 2024 |
20-F filing | 28.0M shares outstanding |
28M | 81M |
| May 16, 2023 |
F-3 filing: This F-3 filing relates to a shelf registration for up to $30,000,000 in the aggregate of American Depositary Shares, ordinary shares, warrants, subscription rights and/or units, as well as an ATM offering of up to $3,500,000 in American Depositary Shares through Aegis Capital Corp. |
24M | 81M |
| May 03, 2023 |
20-F filing | 24.7M shares outstanding |
25M | 81M |
| Apr 29, 2022 |
20-F filing | 316.4M shares outstanding |
320M | 81M |
| May 14, 2021 |
20-F filing | 316.4M shares outstanding |
320M | 81M |
| Dec 02, 2020 |
POS AM filing: This POS AM filing details previous warrant issuances to purchase ADSs in 2017 and 2018 offered pursuant to Rule 506 of Regulation D and Section 4(a)(2) of the Securities Act, and the issuance of ADS in 2019 was made in reliance on an exemption pursuant to Regulation S. |
150M | 81M |
| Nov 02, 2020 |
F-1 filing: The filing is an F-1 form for an offering of American Depositary Shares (ADSs) representing ordinary shares, with the ADSs listed on the Nasdaq Capital Market under the symbol 'MDGS'. |
150M | 81M |
| Apr 21, 2020 |
F-3 filing: This prospectus relates to the disposition from time to time of up to 4,035,193 American Depositary Shares, each representing twenty (20) of our ordinary shares of Medigus Ltd., which are issuable upon the exercise of warrants that have been offered and sold in two public offerings by Medigus. |
N/A | 81M |
| Apr 21, 2020 |
20-F filing | 82.6M shares outstanding |
83M | 81M |